redbiotec

Exomnis Biotech

This company develops engineered bacteria as delivery vehicles for cancer immunotherapies, serving pharmaceutical companies and clinical researchers.

General Biotechnologies

This company develops genetically programmed edible microbes to manufacture oral peptide therapeutics for patients with metabolic diseases and other chronic conditions.

EdiTy Therapeutics

This company develops immune cell delivery platforms to transport therapeutic proteins into diseased cells for patients with cancer and genetic disorders.

Bitrobius Genetics

This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.

Dogma Biotech

This company develops AI-designed glycans to enhance protein therapeutic performance for patients with central nervous system and lysosomal storage diseases.

Protuoso Biosciences

This company develops multifunctional recombinant fusion proteins for pharmaceutical researchers and clinicians treating cardiometabolic, oncological and autoimmune diseases.

Redona Therapeutics

This biotechnology company develops small molecule therapies targeting nucleic acid regulators to treat cancer and autoimmune diseases for healthcare providers and pharmaceutical partners.

Be Biopharma

This company develops engineered B cell medicines to treat patients with hemophilia B, genetic diseases, and cancer.